Profiling the HER3/PI3K Pathway in Breast Tumors
Author Information
Author(s): Mukherjee Ali, Badal Youssouf, Nguyen Xuan-Thao, Miller Johanna, Chenna Ahmed, Tahir Hasan, Newton Alicia, Parry Gordon, Williams Stephen
Primary Institution: Department of Oncology, Monogram Biosciences, South San Francisco, California, United States of America
Hypothesis
Can proximity-directed assays measure protein interactions and phosphorylation in breast cancer samples?
Conclusion
The study demonstrates that proximity-directed assays can effectively measure HER3/PI3K pathway activation in breast tumors.
Supporting Evidence
- The study identified strong correlations between HER3 phosphorylation and receptor interactions.
- 22 out of 27 breast tumors showed positive HER3PI3K assay results.
- The assay system allows for quantitative measurement of therapeutic responses.
Takeaway
Researchers created a new test to see how proteins in breast cancer cells interact, which helps understand how to treat the disease better.
Methodology
The study used proximity-directed assays to measure protein interactions and phosphorylation in formalin-fixed, paraffin-embedded breast cancer samples.
Potential Biases
Potential bias due to funding from Monogram Biosciences, where all authors are employed.
Limitations
The study did not seek ethics committee approval as it did not involve human or animal experiments.
Participant Demographics
The study involved breast cancer cell lines and tumor samples, but specific demographics of participants were not detailed.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website